Compound information
- Natural Products
- ZC3051604
- Molecular Formula
- C29H29N7O2
- Molecular Weight
- 507.238273168 g/mol
- Structure
-
- IUPAC Name
- 3-[4-(dimethylamino)but-2-enoylamino]-N-[3-methyl-4-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide
- InChI
- InChI=1S/C29H29N7O2/c1-20-17-24(11-12-25(20)34-29-31-15-13-26(35-29)22-8-5-14-30-19-22)33-28(38)21-7-4-9-23(18-21)32-27(37)10-6-16-36(2)3/h4-15,17-19H,16H2,1-3H3,(H,32,37)(H,33,38)(H,31,34,35)
- InChI Key
- GJFCSAPFHAXMSF-UHFFFAOYSA-N
- SMILES
- Cc1cc(NC(=O)c2cccc(NC(=O)C=CCN(C)C)c2)ccc1Nc1nccc(-c2cccnc2)n1
- Source
- ZINC001857741842
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 38 | Ring Count | 4 |
Heteroatom Count | 9 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 7 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 112.14 Å2 | LogP | 3.491 |
LogS | -4.068 | LogD | 3.237 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.151 | Pgp substrate | 0.332 |
HIA | 0.965 | F20 % | 0.984 |
F30 % | 0.676 | Caco-2 | -4.877 |
MDCK | -5.437 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.067 | PPB | 85.594 |
VD | 1.48 | Fu | 1.837 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.978 | CYP1A2 substrate | 0.748 |
CYP2A6 substrate | 0.192 | CYP2B6 substrate | 0.658 |
CYP2C19 inhibitor | 0.36 | CYP2C19 substrate | 0.896 |
CYP2C8 substrate | 0.93 | CYP2C9 inhibitor | 0.195 |
CYP2C9 substrate | 0.682 | CYP2D6 inhibitor | 0.797 |
CYP2D6 substrate | 0.955 | CYP2E1 substrate | 0.256 |
CYP3A4 inhibitor | 0.913 | CYP3A4 substrate | 0.991 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.421 | CL | 5.952 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.205 | Hepatotoxicity | 0.932 |
Mutagenicity | 0.013 | Rat Oral Acute Toxicity | 0.069 |
FDAMDD | 0.928 | Skin Sensitization | 0.935 |
Carcinogenicity | 0.018 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.994 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.304 | IGC50 | 4.249 |
LC50FM | -1.272 | LC50DM | 0.606 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.369 | NR-AR-LBD | 0.348 |
NR-AhR | 0.971 | NR-Aromatase | 0.657 |
NR-ER | 0.824 | NR-ER-LBD | 0.533 |
NR-PPAR-gamma | 0.908 | SR-ARE | 0.949 |
SR-ATAD5 | 0.814 | SR-HSE | 0.752 |
SR-MMP | 0.958 | SR-p53 | 0.9 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.